Date:1/8/2013

ogy market in the United States, 2011 193Figure 139: Factors influencing the threat of substitutes in the biotechnology market in the United States, 2011 194Figure 140: Drivers of degree of rivalry in the biotechnology market in the United States, 2011 195Figure 141: Amgen, Inc.: revenues & profitability 200Figure 142: Amgen, Inc.: assets & liabilities 200Figure 143: Covance Inc.: revenues & profitability 203Figure 144: Covance Inc.: assets & liabilities 203Figure 145: Merck & Co., Inc.: revenues & profitability 206Figure 146: Merck & Co., Inc.: assets & liabilities 206Figure 147: F. Hoffmann-La Roche Ltd: revenues & profitability 209Figure 148: F. Hoffmann-La Roche Ltd: assets & liabilities 209Figure 149: Astellas Pharma Inc.: revenues & profitability 212Figure 150: Astellas Pharma Inc.: assets & liabilities 212Figure 151: Kyowa Hakko Kirin Co., Ltd.: revenues & profitability 215Figure 152: Kyowa Hakko Kirin Co., Ltd.: assets & liabilities 215Figure 153: Mitsubishi Tanabe Pharma Corporation: revenues & profitability 217Figure 154: Mitsubishi Tanabe Pharma Corporation: assets & liabilities 218Figure 155: AstraZeneca PLC: revenues & profitability 221Figure 156: AstraZeneca PLC: assets & liabilities 221Figure 157: Boehringer Ingelheim GmbH: revenues & profitability 224Figure 158: Boehringer Ingelheim GmbH: assets & liabilities 224Figure 159: bioMerieux SA: revenues & profitability 228Figure 160: bioMerieux SA: assets & liabilities 228Figure 161: Transgene S.A.: revenues & profitability 231Figure 162: Transgene S.A.: assets & liabilities 231Figure 163: MorphoSys AG: revenues & profitability 234Figure 164: MorphoSys AG: assets & liabilities 234Figure 165: Gentium S.p.A.: revenues & profitability 237Figure 166: Gentium S.p.A.: assets & liabilities 237Figure 167: Daiichi Sankyo Co., Ltd.: revenues & profitability 242Figure 168: Daiichi Sankyo Co., Ltd.: asse
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related biology technology :

1. WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry
2. Lucintel’s Analysis of the Global Glass Mat Thermoplastics Industry: Market is Expected to Reach US $481 Million in 2017
3. Lucintel Performs Competitive Analysis on Top Five Global Consumer Electronic Companies
4. Global Pre-Clinical Imaging Market Analyzed & Forecast by MarketsandMarkets in Report Now Available at MarketPublishers.com
5. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
6. ISPE Announces 2012 Award Winners at Global Annual Meeting
7. Global Agricultural Biotechnology Industry
8. Global Membrane Bioreactor (MBR) Systems Market Worth $2,052 Million by 2017
9. BioNeutral Group Receives Positive Testing Results From A Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores
10. Chemotherapy Induced Nausea and Vomiting (CINV) Existing and Pipeline Drugs Market is Expected to Reach USD 2.1 Billion Globally in 2018: Transparency Market Research
11. Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes